Susanna High

2023

In 2023, Susanna High earned a total compensation of $2M as Chief Operating Officer at Dyne Therapeutics, a 28% increase compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$258,902
Option Awards$255,220
Salary$497,888
Stock Awards$1,032,436
Other$996
Total$2,045,442

High received $1M in stock awards, accounting for 50% of the total pay in 2023.

High also received $258.9K in non-equity incentive plan, $255.2K in option awards, $497.9K in salary and $996 in other compensation.

Rankings

In 2023, Susanna High's compensation ranked 513th out of 2,983 executives tracked by ExecPay. In other words, High earned more than 82.8% of executives.

ClassificationRankingPercentile
All
513
out of 2,983
83rd
Division
Manufacturing
294
out of 1,637
82nd
Major group
Chemicals And Allied Products
204
out of 906
78th
Industry group
Drugs
201
out of 869
77th
Industry
Pharmaceutical Preparations
127
out of 627
80th
Source: SEC filing on April 5, 2024.

High's colleagues

We found two more compensation records of executives who worked with Susanna High at Dyne Therapeutics in 2023.

2023

Josh Brumm

Dyne Therapeutics

Chief Executive Officer

2023

Jonathan McNeill

Dyne Therapeutics

Chief Business Officer

News

You may also like